Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

SpyGlass Pharma secures $75 million in Series D funding to enhance its innovative drug delivery platform for long-term ...

SpyGlass Pharma has closed a Series D funding round, raising $75m to advance the company's drug delivery platform to offer ...

Refalo-Azzopardi, S. and Caruana, C. (2025) Case Report: High Intraocular Pressure vs Temporal Arteritis, a Diagnostic ...

For open-angle glaucoma or ocular hypertension well controlled by eye drops, secondary selective laser trabeculoplasty ...

The new offering, designed specifically for prefilled syringes used in various applications, complements its 1 mL ImProject ...

The tear film coating the eye offers a window into a person's systemic and ocular health, carrying biomarkers such as glucose ...

In a major step toward combating glaucoma, the leading cause of irreversible blindness in Ghana, St. Thomas Eye Hospital has ...

Did you know that glaucoma is an irreversible but preventable cause of blindness worldwide, accounting for 8% of global ...